Technology | 2016.04.01
Global Stem Cells Group Announces Manufacturing Phase of Progenikine™ SVF Closed System
Global Stem Cells Group has begun the manufacturing phase of Progenikine™, a new SVF closed system kit utilizing EmCyte technology, containing all the elements necessary to process adipose tissue and obtain stromal vascular fraction in a sterile environment
(PRWeb March 31, 2016)
Read the full story at http://www.prweb.com/releases/GlobalStemCellsGroup/Progenikine/prweb13306646.htm
For more information, please visit
http://www.prweb.com/releases/GlobalStem[...]/Progenikine/prweb13306646.htm
